Usually, when a drug company's biggest-selling product gets new competition, that's bad news for the king of the hill.
But when the company is ViroPharma Inc., of Exton, and its antibiotic is Vancocin, such a development is more nuanced.
It's great to see Azavea Inc. and Stroll L.L.C., both of Philadelphia, make the Inner City 100 list again.
That's an annual ranking by the Initiative for a Competitive Inner City of the fastest-growing companies in urban cores where the unemployment and poverty rates are higher than the surrounding region.
Ho-hum, Philadelphia's third-tallest building is changing hands.
Two Liberty Place, built for Cigna Corp. in the late 1980s, is being purchased by the Teacher Retirement System of Texas and Parkway Properties Inc., a real estate investment trust in Jackson, Miss., in a deal struck in April.
While every week is small-business week here in The Inquirer's Business section on Mondays, the real thing will be held May 16 to 20.
No sooner had Styron L.L.C. moved into its new corporate headquarters in Berwyn than it announced a name change is in the offing.
April showers seem to be bringing lots of opinions about the state of Philadelphia.
Mayor Nutter presented his "State of the City" address to a business audience at the Union League of Philadelphia last week. A few days before, the Pew Charitable Trust's Philadelphia Research Initiative released its sobering report on how the city is performing, or more precisely underperforming, vs. other cities.
Unisys Corp. has a minor fight on its hands over its executive compensation practices.
Like all companies including a "say-on-pay" advisory vote this year, Unisys is asking shareholders to approve of the way it pays senior executives.
Many shareholders never bother to attend an annual shareholders meeting, and usually they're not missing much.
There are few fireworks. The little interaction that occurs between management and the audience is strictly managed, and often the meeting is over in a matter of minutes.
There is a big difference between being paid by a pharmaceutical company for speaking at a conference about a new treatment and conducting clinical studies on it.
Once, New Jersey's
Gov. Christie said that Pennsylvania was "eating our lunch" when it came to providing incentives to attract and keep companies.
PhillyInc: This time of year, not many people willingly go to see the IRS. But there I was, invited - not summoned - to the agency's new Philadelphia operations in the former 30th Street Post Office.
I received some interesting reactions from readers to Friday's column about the legacy of two pioneers of the region's biotechnology sector.
The Wharton School at the University of Pennsylvania is going back to high school.
Not for remedial economics or to try to pass Phys. Ed., but as part of a mission to boost the financial literacy of students younger than its usual audience.
Inquirer business columnist Mike Armstrong and other staff writers take you beyond the business headlines in Philadelphia.